Clinical trial
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled…
NCT00475085 · Joseph Roscoe, Other · Completed
Key facts
| NCT number | NCT00475085 |
|---|---|
| Title | Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial |
| Official title | Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial |
| Lead sponsor | Joseph Roscoe, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nausea |
| Intervention type | Drug |
| Interventions | aprepitant, dexamethasone, granisetron hydrochloride, palonosetron hydrochloride, prochlorperazine, placebo |
| Enrollment | 1,021 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2012 |
| First posted | May 17, 2007 |
| Last update posted | Nov 10, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: